Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00291772 · ClinicalTrials.gov registry record · Phase 4
Continuous Subcutaneous Infusion of Pramlintide and Insulin
A Phase 4 study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 13
- Enrollment target
NCT00291772 is a Phase 4 study that has completed, run by Baylor College of Medicine. The registered enrollment target is 13 participants.
The verdict
NCT00291772, a Phase 4 study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this study is to see if giving the study drug in a slow and steady dose will lower blood sugars during the meal and after-meal time.
Interventions
- DRUG Pramlintide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2006-01 |
| Est. Completion | 2007-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00291772
The ClinicalTrials.gov registry entry for NCT00291772 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pramlintide is the first listed.
NCT00291772 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00291772 about?
NCT00291772 is a clinical study titled "Continuous Subcutaneous Infusion of Pramlintide and Insulin". The purpose of this study is to see if giving the study drug in a slow and steady dose will lower blood sugars during the meal and after-meal time.
What is the current status of trial NCT00291772?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 13 participants. The study started on 2006-01. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00291772?
The interventions under investigation include: Pramlintide (DRUG).
Who is sponsoring clinical trial NCT00291772?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.